These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 33587820

  • 1. Deep Learning Corpus Callosum Segmentation as a Neurodegenerative Marker in Multiple Sclerosis.
    Platten M, Brusini I, Andersson O, Ouellette R, Piehl F, Wang C, Granberg T.
    J Neuroimaging; 2021 May; 31(3):493-500. PubMed ID: 33587820
    [Abstract] [Full Text] [Related]

  • 2. Automatic deep learning multicontrast corpus callosum segmentation in multiple sclerosis.
    Brusini I, Platten M, Ouellette R, Piehl F, Wang C, Granberg T.
    J Neuroimaging; 2022 May; 32(3):459-470. PubMed ID: 35083815
    [Abstract] [Full Text] [Related]

  • 3. MRI-Defined Corpus Callosal Atrophy in Multiple Sclerosis: A Comparison of Volumetric Measurements, Corpus Callosum Area and Index.
    Granberg T, Bergendal G, Shams S, Aspelin P, Kristoffersen-Wiberg M, Fredrikson S, Martola J.
    J Neuroimaging; 2015 May; 25(6):996-1001. PubMed ID: 25786805
    [Abstract] [Full Text] [Related]

  • 4. MRI-Based Manual versus Automated Corpus Callosum Volumetric Measurements in Multiple Sclerosis.
    Platten M, Martola J, Fink K, Ouellette R, Piehl F, Granberg T.
    J Neuroimaging; 2020 Mar; 30(2):198-204. PubMed ID: 31750599
    [Abstract] [Full Text] [Related]

  • 5. A validation study of manual atrophy measures in patients with Multiple Sclerosis.
    Cappelle S, Pareto D, Tintoré M, Vidal-Jordana A, Alyafeai R, Alberich M, Sastre-Garriga J, Auger C, Montalban X, Rovira À.
    Neuroradiology; 2020 Aug; 62(8):955-964. PubMed ID: 32246177
    [Abstract] [Full Text] [Related]

  • 6. Corpus callosum atrophy is strongly associated with cognitive impairment in multiple sclerosis: Results of a 17-year longitudinal study.
    Granberg T, Martola J, Bergendal G, Shams S, Damangir S, Aspelin P, Fredrikson S, Kristoffersen-Wiberg M.
    Mult Scler; 2015 Aug; 21(9):1151-8. PubMed ID: 25480866
    [Abstract] [Full Text] [Related]

  • 7. 'Importance sampling' in MS: use of diffusion tensor tractography to quantify pathology related to specific impairment.
    Lin X, Tench CR, Morgan PS, Niepel G, Constantinescu CS.
    J Neurol Sci; 2005 Oct 15; 237(1-2):13-9. PubMed ID: 16109428
    [Abstract] [Full Text] [Related]

  • 8. Corpus callosum axon diameter relates to cognitive impairment in multiple sclerosis.
    Huang SY, Fan Q, Machado N, Eloyan A, Bireley JD, Russo AW, Tobyne SM, Patel KR, Brewer K, Rapaport SF, Nummenmaa A, Witzel T, Sherman JC, Wald LL, Klawiter EC.
    Ann Clin Transl Neurol; 2019 May 15; 6(5):882-892. PubMed ID: 31139686
    [Abstract] [Full Text] [Related]

  • 9. The relationship between total and regional corpus callosum atrophy, cognitive impairment and fatigue in multiple sclerosis patients.
    Yaldizli Ö, Penner IK, Frontzek K, Naegelin Y, Amann M, Papadopoulou A, Sprenger T, Kuhle J, Calabrese P, Radü EW, Kappos L, Gass A.
    Mult Scler; 2014 Mar 15; 20(3):356-64. PubMed ID: 23959709
    [Abstract] [Full Text] [Related]

  • 10. Corpus callosum index correlates with brain volumetry and disability in multiple sclerosis patients.
    Sugijono SE, Mulyadi R, Firdausia S, Prihartono J, Estiasari R.
    Neurosciences (Riyadh); 2020 Jul 15; 25(3):193-199. PubMed ID: 32683399
    [Abstract] [Full Text] [Related]

  • 11. Reliability of measuring regional callosal atrophy in neurodegenerative diseases.
    Van Schependom J, Jain S, Cambron M, Vanbinst AM, De Mey J, Smeets D, Nagels G.
    Neuroimage Clin; 2016 Jul 15; 12():825-831. PubMed ID: 27830115
    [Abstract] [Full Text] [Related]

  • 12. Enhanced choroid plexus segmentation with 3D UX-Net and its association with disease progression in multiple sclerosis.
    Wang X, Wang X, Yan Z, Yin F, Li Y, Liu X, Liu Y.
    Mult Scler Relat Disord; 2024 Aug 15; 88():105750. PubMed ID: 38986172
    [Abstract] [Full Text] [Related]

  • 13. Cortical and white matter lesion topology influences focal corpus callosum atrophy in multiple sclerosis.
    Platten M, Ouellette R, Herranz E, Barletta V, Treaba CA, Mainero C, Granberg T.
    J Neuroimaging; 2022 May 15; 32(3):471-479. PubMed ID: 35165979
    [Abstract] [Full Text] [Related]

  • 14. The effect of morphological and microstructural integrity of the corpus callosum on cognition, fatigue and depression in mildly disabled MS patients.
    Van Schependom J, Gielen J, Laton J, Sotiropoulos G, Vanbinst AM, De Mey J, Smeets D, Nagels G.
    Magn Reson Imaging; 2017 Jul 15; 40():109-114. PubMed ID: 28438714
    [Abstract] [Full Text] [Related]

  • 15. MRI of the corpus callosum in multiple sclerosis: association with disability.
    Ozturk A, Smith SA, Gordon-Lipkin EM, Harrison DM, Shiee N, Pham DL, Caffo BS, Calabresi PA, Reich DS.
    Mult Scler; 2010 Feb 15; 16(2):166-77. PubMed ID: 20142309
    [Abstract] [Full Text] [Related]

  • 16. Midsagittal corpus callosum area and conversion to multiple sclerosis after clinically isolated syndrome: A multicentre Australian cohort study.
    Odenthal C, Simpson S, Oughton J, van der Mei I, Rose S, Fripp J, Lucas R, Taylor B, Dear K, Ponsonby AL, Coulthard A, Ausimmune AusLong Investigator Groups.
    J Med Imaging Radiat Oncol; 2017 Aug 15; 61(4):453-460. PubMed ID: 27995735
    [Abstract] [Full Text] [Related]

  • 17. Corpus callosum volumetrics and clinical progression in early multiple sclerosis.
    Sotgiu MA, Piga G, Mazzarello V, Zarbo IR, Carta A, Saderi L, Sotgiu S, Conti M, Saba L, Crivelli P.
    Eur Rev Med Pharmacol Sci; 2022 Jan 15; 26(1):225-231. PubMed ID: 35048999
    [Abstract] [Full Text] [Related]

  • 18. Corpus callosum atrophy--a simple predictor of multiple sclerosis progression: a longitudinal 9-year study.
    Vaneckova M, Kalincik T, Krasensky J, Horakova D, Havrdova E, Hrebikova T, Seidl Z.
    Eur Neurol; 2012 Jan 15; 68(1):23-7. PubMed ID: 22677920
    [Abstract] [Full Text] [Related]

  • 19. Accurate, rapid and reliable, fully automated MRI brainstem segmentation for application in multiple sclerosis and neurodegenerative diseases.
    Sander L, Pezold S, Andermatt S, Amann M, Meier D, Wendebourg MJ, Sinnecker T, Radue EW, Naegelin Y, Granziera C, Kappos L, Wuerfel J, Cattin P, Schlaeger R, Alzheimer's Disease Neuroimaging Initiative.
    Hum Brain Mapp; 2019 Oct 01; 40(14):4091-4104. PubMed ID: 31206931
    [Abstract] [Full Text] [Related]

  • 20. Deep learning segmentation of the choroid plexus from structural magnetic resonance imaging (MRI): validation and normative ranges across the adult lifespan.
    Eisma JJ, McKnight CD, Hett K, Elenberger J, Han CJ, Song AK, Considine C, Claassen DO, Donahue MJ.
    Fluids Barriers CNS; 2024 Feb 29; 21(1):21. PubMed ID: 38424598
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.